ANAGRELIDE

ANAGRELIDE was reported 1175 times

ANAGRELIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLUCOSE-6-PHOSPHATE DEHYDROGENASE 1 0.5000
1 ABDOMINAL X-RAY 1 0.1111
2 COMMUNITY ACQUIRED INFECTION 3 0.0536
3 ORAL SUBMUCOSAL FIBROSIS 1 0.0526
4 BONE MARROW RETICULIN FIBROSIS 10 0.0388
5 PERIPROCEDURAL MYOCARDIAL INFARCTION 1 0.0385
6 BLOOD ERYTHROPOIETIN DECREASED 2 0.0345
7 PLASMA PROTEIN METABOLISM DISORDER 1 0.0323
8 CHEST X-RAY 1 0.0286
9 AQUAGENIC PRURITUS 2 0.0244
10 DIFFUSE LARGE B-CELL LYMPHOMA STAGE I 1 0.0238
11 PERIORBITAL HAEMORRHAGE 5 0.0230
12 CYTOKINE ABNORMAL 1 0.0192
13 SHORTENED CERVIX 5 0.0171
14 ESSENTIAL THROMBOCYTHAEMIA 6 0.0163
15 BIOPSY LYMPH GLAND ABNORMAL 1 0.0156
16 PAROTID ABSCESS 1 0.0154
17 PELVIC CYST 2 0.0146
18 HAEMATOLOGICAL NEOPLASM 1 0.0145
19 PULMONARY ENDARTERECTOMY 2 0.0137
20 GINGIVAL PRURITUS 1 0.0116
21 MYELOFIBROSIS 34 0.0112
22 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 1 0.0108
23 MUSCULOSKELETAL TOXICITY 2 0.0108
24 FACTOR V INHIBITION 2 0.0103
25 LEUKOERYTHROBLASTOSIS 1 0.0100
26 ANEMBRYONIC GESTATION 2 0.0096
27 OESOPHAGEAL INTRAMURAL HAEMATOMA 1 0.0095
28 MYELOPROLIFERATIVE NEOPLASM 6 0.0090
29 MENINGITIS PNEUMOCOCCAL 3 0.0082
30 ERYTHROMELALGIA 3 0.0082
31 CENTRAL VENOUS PRESSURE INCREASED 1 0.0082
32 PRINZMETAL ANGINA 8 0.0080
33 CALCIFICATION OF MUSCLE 1 0.0080
34 BURNING FEET SYNDROME 2 0.0080
35 PLATELET COUNT INCREASED 103 0.0079
36 COMPUTERISED TOMOGRAM 1 0.0072
37 CERVIX DISORDER 5 0.0069
38 BASOSQUAMOUS CARCINOMA 1 0.0067
39 ASPERGILLUS TEST POSITIVE 2 0.0065
40 THROMBOCYTOSIS 23 0.0063
41 VENTRICULAR TACHYARRHYTHMIA 2 0.0063
42 PRIMARY MYELOFIBROSIS 2 0.0062
43 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 2 0.0061
44 PERITONEAL PERFORATION 1 0.0061
45 PROTEIN-LOSING GASTROENTEROPATHY 3 0.0060
46 PELVIC FLOOR MUSCLE WEAKNESS 1 0.0058
47 ATRIAL SEPTAL DEFECT REPAIR 1 0.0058
48 ANAL INJURY 1 0.0058
49 BONE MARROW MYELOGRAM ABNORMAL 1 0.0057
50 EYELID INJURY 1 0.0057
51 CEREBRAL VENTRICULAR RUPTURE 1 0.0055
52 SKIN ULCER HAEMORRHAGE 2 0.0052
53 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
54 BENIGN HEPATIC NEOPLASM 1 0.0050
55 OCULAR ROSACEA 1 0.0049
56 MALIGNANT MELANOMA STAGE III 1 0.0049
57 ADENOCARCINOMA METASTATIC 1 0.0049
58 METASTASES TO EYE 1 0.0046
59 ALDOLASE INCREASED 1 0.0044
60 PUNCTURE SITE HAEMORRHAGE 3 0.0042
61 CANCER IN REMISSION 1 0.0041
62 NAIL PIGMENTATION 1 0.0041
63 GASTRIC MUCOSAL HYPERTROPHY 1 0.0040
64 ORAL LICHEN PLANUS 2 0.0040
65 INTRAOCULAR PRESSURE DECREASED 2 0.0038
66 POLYCYTHAEMIA VERA 3 0.0037
67 CHOROIDAL DETACHMENT 2 0.0036
68 VISUAL ACUITY TESTS ABNORMAL 2 0.0036
69 DYSAESTHESIA 11 0.0036
70 METASTASES TO NECK 1 0.0036
71 ADNEXA UTERI MASS 1 0.0035
72 PUPILLARY DISORDER 2 0.0033
73 ERYTHROPOIESIS ABNORMAL 1 0.0033
74 VASOSPASM 3 0.0033
75 APOPTOSIS 1 0.0032
76 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 1 0.0032
77 PLATELET COUNT ABNORMAL 19 0.0031
78 HAEMATOLOGY TEST ABNORMAL 1 0.0031
79 BLAST CELL CRISIS 1 0.0030
80 INFLAMMATION OF WOUND 1 0.0030
81 DYSPNOEA PAROXYSMAL NOCTURNAL 2 0.0027
82 NON-SMALL CELL LUNG CANCER STAGE IV 1 0.0027
83 ACINETOBACTER INFECTION 3 0.0027
84 BODY DYSMORPHIC DISORDER 1 0.0027
85 HYPERLACTACIDAEMIA 7 0.0026
86 CEREBRAL ARTERIOSCLEROSIS 1 0.0026
87 FULL BLOOD COUNT INCREASED 3 0.0025
88 EYE INFECTION TOXOPLASMAL 1 0.0025
89 DEPENDENCE ON RESPIRATOR 1 0.0025
90 CHOROIDAL EFFUSION 2 0.0025
91 PERSISTENT DEPRESSIVE DISORDER 1 0.0025
92 OROPHARYNGEAL PLAQUE 1 0.0025
93 ARTHROPOD STING 4 0.0024
94 EROSIVE OESOPHAGITIS 4 0.0024
95 SPLENOMEGALY 27 0.0023
96 DEGENERATIVE BONE DISEASE 1 0.0023
97 MUSCLE ENZYME INCREASED 1 0.0023
98 MALIGNANT TRANSFORMATION 1 0.0022
99 PROTHROMBIN TIME SHORTENED 3 0.0021
100 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 1 0.0021
101 BLOOD IRON INCREASED 4 0.0021
102 CEREBRAL ARTERY STENOSIS 1 0.0020
103 ELECTROLYTE DEPLETION 1 0.0020
104 LENTIGO 1 0.0020
105 MYELOID LEUKAEMIA 1 0.0020
106 HEAT STROKE 3 0.0020
107 METASTATIC SQUAMOUS CELL CARCINOMA 1 0.0020
108 CONGESTIVE CARDIOMYOPATHY 8 0.0019
109 BLAST CELL COUNT INCREASED 2 0.0019
110 GRIEF REACTION 1 0.0019
111 TRAUMATIC HAEMATOMA 2 0.0019
112 BLOOD GASES ABNORMAL 1 0.0019
113 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
114 LIMB MASS 4 0.0018
115 RESUSCITATION 3 0.0018
116 HAEMATOCRIT INCREASED 4 0.0018
117 CARDIORENAL SYNDROME 1 0.0017
118 TRANSPLANT DYSFUNCTION 3 0.0017
119 ADRENAL ADENOMA 1 0.0017
120 HYPERPARATHYROIDISM SECONDARY 4 0.0016
121 ANION GAP 1 0.0016
122 LIP HAEMORRHAGE 2 0.0016
123 PAROTID GLAND ENLARGEMENT 1 0.0015
124 NAIL DISCOLOURATION 6 0.0015
125 OBLITERATIVE BRONCHIOLITIS 2 0.0015
126 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
127 CORONARY ARTERY THROMBOSIS 3 0.0015
128 ABSCESS NECK 1 0.0015
129 MACULAR FIBROSIS 1 0.0015
130 TONGUE DRY 2 0.0015
131 NORMAL NEWBORN 8 0.0015
132 MARROW HYPERPLASIA 1 0.0015
133 VASCULAR OCCLUSION 3 0.0014
134 CEREBELLAR HAEMORRHAGE 2 0.0014
135 DYSHIDROTIC ECZEMA 1 0.0014
136 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
137 FOETAL EXPOSURE TIMING UNSPECIFIED 1 0.0014
138 NASAL INJURY 1 0.0014
139 LARYNGEAL DISORDER 1 0.0014
140 CAROTID ARTERY OCCLUSION 5 0.0014
141 ACUTE ABDOMEN 2 0.0014
142 MICROALBUMINURIA 1 0.0013
143 BASOPHIL COUNT INCREASED 1 0.0013
144 DEVICE DAMAGE 1 0.0013
145 ENTEROCOCCAL INFECTION 6 0.0012
146 TRANSPLANT FAILURE 3 0.0012
147 GRANULOMA SKIN 1 0.0012
148 MITOCHONDRIAL TOXICITY 1 0.0012
149 OESOPHAGEAL PERFORATION 1 0.0012
150 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
151 CATHETER SITE PRURITUS 1 0.0011
152 ABDOMINAL SEPSIS 1 0.0011
153 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
154 CATHETER MANAGEMENT 1 0.0011
155 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
156 ADENOCARCINOMA GASTRIC 1 0.0011
157 RENAL FUNCTION TEST ABNORMAL 5 0.0011
158 MICROANGIOPATHY 1 0.0011
159 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
160 ACTINOMYCOSIS 1 0.0010
161 STRESS CARDIOMYOPATHY 6 0.0010
162 NEUROENDOCRINE CARCINOMA OF THE SKIN 1 0.0010
163 HAEMOPHILUS INFECTION 1 0.0010
164 GENE MUTATION 2 0.0010
165 BLOOD DISORDER 8 0.0010
166 HEPATITIS B 6 0.0010
167 LYMPHOCYTIC INFILTRATION 1 0.0010
168 RENAL HAEMORRHAGE 2 0.0010
169 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
170 CORONAVIRUS TEST POSITIVE 1 0.0010
171 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
172 HYPERTENSIVE NEPHROPATHY 1 0.0009
173 PANCREATIC MASS 1 0.0009
174 HAEMOGLOBIN ABNORMAL 6 0.0009
175 IRON OVERLOAD 1 0.0009
176 BLOOD POTASSIUM INCREASED 15 0.0009
177 BLOOD COUNT ABNORMAL 14 0.0009
178 HERPES SIMPLEX 6 0.0009
179 POSTURE ABNORMAL 3 0.0009
180 PILOERECTION 1 0.0009
181 ONYCHOMYCOSIS 4 0.0009
182 HAEMATOCRIT DECREASED 18 0.0009
183 CORONAVIRUS INFECTION 6 0.0009
184 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
185 SKIN ULCER 23 0.0009
186 INCREASED TENDENCY TO BRUISE 8 0.0009
187 PAROTITIS 1 0.0009
188 DILATATION ATRIAL 1 0.0009
189 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
190 URINARY HESITATION 2 0.0008
191 EMBOLISM ARTERIAL 1 0.0008
192 MONOCYTE COUNT DECREASED 1 0.0008
193 DERMAL CYST 2 0.0008
194 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
195 STEM CELL TRANSPLANT 2 0.0008
196 NASAL PRURITUS 1 0.0008
197 PLATELET DISORDER 2 0.0008
198 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
199 INFUSION SITE IRRITATION 1 0.0008
200 ADENOCARCINOMA PANCREAS 1 0.0008
201 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
202 SERUM FERRITIN INCREASED 4 0.0008
203 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
204 ANION GAP INCREASED 1 0.0007
205 ACUTE MYOCARDIAL INFARCTION 22 0.0007
206 INTESTINAL MASS 1 0.0007
207 HAEMOGLOBIN DECREASED 75 0.0007
208 RED BLOOD CELL COUNT INCREASED 2 0.0007
209 RENAL TUBULAR NECROSIS 7 0.0007
210 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
211 BUNDLE BRANCH BLOCK LEFT 3 0.0007
212 MENINGITIS BACTERIAL 1 0.0007
213 HEART VALVE INCOMPETENCE 2 0.0007
214 HEPATIC LESION 3 0.0007
215 COCCYDYNIA 1 0.0007
216 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
217 BLOOD IRON DECREASED 8 0.0007
218 MENTAL FATIGUE 1 0.0007
219 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
220 FULL BLOOD COUNT ABNORMAL 7 0.0007
221 GENITAL HERPES 1 0.0007
222 BLOOD PRESSURE IMMEASURABLE 1 0.0007
223 PNEUMONIA PSEUDOMONAL 1 0.0007
224 DIASTOLIC DYSFUNCTION 2 0.0006
225 MULTIPLE-DRUG RESISTANCE 2 0.0006
226 NEOPLASM SKIN 1 0.0006
227 NON-CARDIAC CHEST PAIN 2 0.0006
228 RED BLOOD CELL COUNT DECREASED 18 0.0006
229 ORTHOPNOEA 2 0.0006
230 BREAST ENLARGEMENT 2 0.0006
231 CARDIOMYOPATHY 9 0.0006
232 LISTLESS 2 0.0006
233 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
234 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
235 CEREBRAL HAEMATOMA 2 0.0006
236 CACHEXIA 3 0.0006
237 PERIPHERAL VASCULAR DISORDER 3 0.0006
238 LEFT VENTRICULAR FAILURE 2 0.0006
239 EXTREMITY NECROSIS 1 0.0006
240 OTORRHOEA 1 0.0006
241 RIGHT VENTRICULAR FAILURE 4 0.0006
242 FOOD INTERACTION 1 0.0006
243 KYPHOSIS 1 0.0006
244 MITRAL VALVE DISEASE 1 0.0006
245 HAEMORRHAGIC DIATHESIS 2 0.0006
246 CUTANEOUS VASCULITIS 2 0.0005
247 METAMORPHOPSIA 1 0.0005
248 UROSEPSIS 5 0.0005
249 CYTOMEGALOVIRUS INFECTION 9 0.0005
250 HYPERTENSIVE CRISIS 6 0.0005
251 BLOOD CHOLESTEROL DECREASED 1 0.0005
252 INTERMENSTRUAL BLEEDING 3 0.0005
253 ACUTE PULMONARY OEDEMA 3 0.0005
254 BONE MARROW TRANSPLANT 1 0.0005
255 NEUTROPHILIA 3 0.0005
256 MYOCARDIAL ISCHAEMIA 6 0.0005
257 MOTION SICKNESS 1 0.0005
258 ARTERIAL THROMBOSIS 1 0.0005
259 EARLY SATIETY 1 0.0005
260 NASAL SEPTUM DEVIATION 1 0.0005
261 CONCOMITANT DISEASE PROGRESSION 1 0.0005
262 PROSTATOMEGALY 2 0.0005
263 HAEMOPTYSIS 14 0.0005
264 LIPIDS INCREASED 1 0.0005
265 POLYCYTHAEMIA 1 0.0005
266 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
267 SECOND PRIMARY MALIGNANCY 4 0.0005
268 ATRIAL TACHYCARDIA 1 0.0005
269 DILATATION VENTRICULAR 1 0.0005
270 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
271 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
272 DECREASED ACTIVITY 5 0.0005
273 CARDIAC MURMUR 4 0.0005
274 HORDEOLUM 2 0.0005
275 ANGINA UNSTABLE 3 0.0005
276 CHAPPED LIPS 2 0.0005
277 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
278 ORTHOSTATIC HYPOTENSION 8 0.0005
279 ASPERGILLUS INFECTION 3 0.0005
280 EJECTION FRACTION DECREASED 7 0.0004
281 CORNEAL OEDEMA 1 0.0004
282 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
283 GASTRIC POLYPS 1 0.0004
284 HAEMOGLOBIN INCREASED 2 0.0004
285 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
286 CYTOMEGALOVIRUS COLITIS 1 0.0004
287 DROOLING 3 0.0004
288 LARGE INTESTINE POLYP 3 0.0004
289 PERICARDIAL EFFUSION 10 0.0004
290 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
291 POST PROCEDURAL HAEMORRHAGE 5 0.0004
292 PATELLA FRACTURE 1 0.0004
293 BILIRUBIN CONJUGATED INCREASED 1 0.0004
294 SKIN ABRASION 2 0.0004
295 EOSINOPHIL COUNT DECREASED 1 0.0004
296 SEDATION 11 0.0004
297 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
298 SKIN CANCER 9 0.0004
299 LONG QT SYNDROME 1 0.0004
300 RASH VESICULAR 2 0.0004
301 ORAL INTAKE REDUCED 1 0.0004
302 BRONCHITIS CHRONIC 1 0.0004
303 GLOMERULONEPHRITIS 1 0.0004
304 PANCREATIC DISORDER 2 0.0004
305 SKIN HAEMORRHAGE 6 0.0004
306 ACUTE PSYCHOSIS 1 0.0004
307 NIGHT SWEATS 13 0.0004
308 IMPAIRED HEALING 13 0.0004
309 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
310 DRUG TOLERANCE 2 0.0004
311 DERMATOMYOSITIS 1 0.0004
312 CANCER PAIN 1 0.0004
313 NEUTROPHIL COUNT INCREASED 4 0.0004
314 HEPATOSPLENOMEGALY 1 0.0004
315 DRUG RESISTANCE 10 0.0004
316 AORTIC ARTERIOSCLEROSIS 1 0.0004
317 EPISTAXIS 29 0.0004
318 VARICOSE VEIN 2 0.0004
319 LEUKOCYTOSIS 7 0.0004
320 ACTINIC KERATOSIS 1 0.0004
321 HERNIA REPAIR 1 0.0004
322 PLATELET COUNT DECREASED 41 0.0004
323 CONTUSION 37 0.0004
324 PRODUCT PRESCRIBING ERROR 9 0.0004
325 BREAST SWELLING 1 0.0004
326 POST PROCEDURAL INFECTION 3 0.0004
327 LIP BLISTER 1 0.0004
328 PLEURITIC PAIN 1 0.0004
329 HEART RATE ABNORMAL 2 0.0004
330 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
331 ANAEMIA 68 0.0004
332 CANDIDA INFECTION 6 0.0004
333 NECK MASS 1 0.0004
334 CEREBRAL THROMBOSIS 1 0.0004
335 SINUS TACHYCARDIA 5 0.0004
336 HAEMATOLOGICAL MALIGNANCY 1 0.0004
337 PRODUCT AVAILABILITY ISSUE 8 0.0004
338 LIP PAIN 1 0.0003
339 SKIN ATROPHY 2 0.0003
340 FULL BLOOD COUNT DECREASED 7 0.0003
341 HYPERTONIC BLADDER 1 0.0003
342 HYPERTRIGLYCERIDAEMIA 2 0.0003
343 CARDIAC FAILURE 27 0.0003
344 ANAL INCONTINENCE 3 0.0003
345 METABOLIC ENCEPHALOPATHY 1 0.0003
346 LIMB INJURY 9 0.0003
347 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
348 PNEUMONIA BACTERIAL 3 0.0003
349 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
350 PANCYTOPENIA 18 0.0003
351 BASAL CELL CARCINOMA 5 0.0003
352 BLOOD BLISTER 1 0.0003
353 NASAL DRYNESS 2 0.0003
354 ARTERIOSCLEROSIS 3 0.0003
355 PHOTOPSIA 2 0.0003
356 BILE DUCT STONE 1 0.0003
357 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
358 DIZZINESS POSTURAL 3 0.0003
359 LIVER ABSCESS 1 0.0003
360 PLASMA CELL MYELOMA RECURRENT 1 0.0003
361 THROMBOTIC MICROANGIOPATHY 3 0.0003
362 HYPOVENTILATION 1 0.0003
363 HEPATOMEGALY 3 0.0003
364 LABORATORY TEST ABNORMAL 9 0.0003
365 WALKING AID USER 2 0.0003
366 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
367 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
368 LYME DISEASE 1 0.0003
369 QUALITY OF LIFE DECREASED 4 0.0003
370 VERTIGO 18 0.0003
371 GINGIVAL BLEEDING 4 0.0003
372 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
373 NEPHROTIC SYNDROME 2 0.0003
374 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
375 TEMPERATURE INTOLERANCE 3 0.0003
376 LOCALISED INFECTION 7 0.0003
377 LYMPHOEDEMA 2 0.0003
378 GRANULOMA 1 0.0003
379 PULMONARY HYPERTENSION 6 0.0003
380 PETECHIAE 3 0.0003
381 MASS 4 0.0003
382 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
383 THERMAL BURN 2 0.0003
384 GLOSSITIS 1 0.0003
385 METABOLIC ACIDOSIS 9 0.0003
386 GOUT 5 0.0003
387 HERPES ZOSTER 16 0.0003
388 GRAFT VERSUS HOST DISEASE 2 0.0003
389 FACIAL BONES FRACTURE 1 0.0003
390 FLUID OVERLOAD 4 0.0003
391 ORAL DISORDER 2 0.0003
392 MOUTH HAEMORRHAGE 2 0.0003
393 HAEMATOMA 7 0.0003
394 VENTRICULAR FIBRILLATION 3 0.0003
395 IMMUNODEFICIENCY 4 0.0003
396 BONE DENSITY ABNORMAL 1 0.0003
397 NEPHROPATHY TOXIC 3 0.0003
398 MITRAL VALVE INCOMPETENCE 3 0.0003
399 PALPITATIONS 31 0.0003
400 LOSS OF CONTROL OF LEGS 1 0.0003
401 FACE INJURY 1 0.0003
402 SCAB 3 0.0003
403 MICTURITION URGENCY 3 0.0003
404 INCREASED APPETITE 5 0.0003
405 COMMUNICATION DISORDER 1 0.0003
406 DRUG INTOLERANCE 25 0.0003
407 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
408 CARDIOPULMONARY FAILURE 1 0.0003
409 PULMONARY HAEMORRHAGE 2 0.0003
410 OEDEMA PERIPHERAL 31 0.0003
411 PNEUMONIA FUNGAL 1 0.0003
412 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
413 TRICUSPID VALVE INCOMPETENCE 2 0.0003
414 AZOTAEMIA 1 0.0003
415 ARTERIOSPASM CORONARY 1 0.0002
416 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
417 BRADYCARDIA 13 0.0002
418 BLOOD CREATININE INCREASED 16 0.0002
419 CYTOPENIA 3 0.0002
420 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
421 HYPERAESTHESIA 2 0.0002
422 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
423 AORTIC DISSECTION 1 0.0002
424 ACUTE CORONARY SYNDROME 2 0.0002
425 BLOOD UREA INCREASED 4 0.0002
426 CHRONIC KIDNEY DISEASE 18 0.0002
427 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
428 AORTIC VALVE INCOMPETENCE 1 0.0002
429 METRORRHAGIA 4 0.0002
430 ABNORMAL SENSATION IN EYE 1 0.0002
431 HEPATIC FAILURE 7 0.0002
432 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
433 PRODUCT DOSE OMISSION 15 0.0002
434 MELANOCYTIC NAEVUS 1 0.0002
435 HAEMORRHAGIC ANAEMIA 1 0.0002
436 TUMOUR LYSIS SYNDROME 2 0.0002
437 RESPIRATORY RATE INCREASED 2 0.0002
438 CARDIOTOXICITY 2 0.0002
439 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
440 IRON DEFICIENCY 1 0.0002
441 RETINAL DETACHMENT 2 0.0002
442 CHRONIC MYELOID LEUKAEMIA 1 0.0002
443 NEPHROGENIC ANAEMIA 1 0.0002
444 CONJUNCTIVITIS 4 0.0002
445 PRODUCT DISTRIBUTION ISSUE 2 0.0002
446 FLANK PAIN 2 0.0002
447 FLATULENCE 12 0.0002
448 THROMBOSIS 17 0.0002
449 COLITIS MICROSCOPIC 1 0.0002
450 CARDIAC TAMPONADE 1 0.0002
451 LIMB OPERATION 1 0.0002
452 APHAGIA 1 0.0002
453 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
454 HYPOGLYCAEMIA 10 0.0002
455 VITAMIN D DEFICIENCY 2 0.0002
456 ORAL HERPES 4 0.0002
457 INCORRECT DOSAGE ADMINISTERED 1 0.0002
458 BREATH SOUNDS ABNORMAL 1 0.0002
459 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
460 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
461 EMPHYSEMA 2 0.0002
462 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
463 BONE MARROW FAILURE 4 0.0002
464 DRY THROAT 2 0.0002
465 SKIN DISCOLOURATION 9 0.0002
466 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
467 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
468 ACUTE MYELOID LEUKAEMIA 3 0.0002
469 WEIGHT INCREASED 43 0.0002
470 TENDERNESS 2 0.0002
471 MALABSORPTION 1 0.0002
472 TACHYCARDIA 17 0.0002
473 TRANSFUSION 2 0.0002
474 FOOD CRAVING 1 0.0002
475 ULCER 3 0.0002
476 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
477 FOOD POISONING 1 0.0002
478 PAIN OF SKIN 5 0.0002
479 BRUXISM 1 0.0002
480 FAECES DISCOLOURED 4 0.0002
481 BACK INJURY 2 0.0002
482 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
483 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
484 ASPIRATION 2 0.0002
485 JAW DISORDER 1 0.0002
486 ASTHENOPIA 1 0.0002
487 CHOKING SENSATION 1 0.0002
488 HYPERKERATOSIS 1 0.0002
489 ON AND OFF PHENOMENON 1 0.0002
490 SKIN DISORDER 6 0.0002
491 FEELING COLD 5 0.0002
492 GLOSSODYNIA 4 0.0002
493 ANGIOPATHY 1 0.0002
494 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
495 SKIN INFECTION 2 0.0002
496 INTESTINAL PERFORATION 2 0.0002
497 MYOCARDITIS 2 0.0002
498 MUSCULOSKELETAL DISCOMFORT 3 0.0002
499 CARDIAC FAILURE CONGESTIVE 14 0.0002
500 NEOPLASM 2 0.0002
501 EXERCISE TOLERANCE DECREASED 1 0.0002
502 HERPES VIRUS INFECTION 1 0.0002
503 BLOOD URIC ACID INCREASED 1 0.0002
504 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
505 ENERGY INCREASED 1 0.0002
506 DRUG DOSE OMISSION 28 0.0002
507 WRIST FRACTURE 2 0.0002
508 HEARING IMPAIRED 1 0.0002
509 OFF LABEL USE 145 0.0002
510 CRYING 6 0.0002
511 C-REACTIVE PROTEIN INCREASED 6 0.0002
512 INGUINAL HERNIA 1 0.0002
513 DERMATITIS ACNEIFORM 1 0.0002
514 ABDOMINAL DISTENSION 17 0.0002
515 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
516 PIGMENTATION DISORDER 1 0.0002
517 CYST 2 0.0002
518 THINKING ABNORMAL 3 0.0002
519 AGEUSIA 4 0.0002
520 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
521 HYPONATRAEMIA 9 0.0002
522 SECRETION DISCHARGE 2 0.0002
523 PHOTOPHOBIA 3 0.0002
524 DYSPNOEA EXERTIONAL 6 0.0002
525 CELLULITIS 8 0.0002
526 FRACTURE 3 0.0002
527 COLITIS 6 0.0002
528 BLOOD URINE PRESENT 3 0.0002
529 COLITIS ULCERATIVE 7 0.0002
530 ACUTE RESPIRATORY FAILURE 3 0.0002
531 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
532 RENAL IMPAIRMENT 13 0.0002
533 APPLICATION SITE VESICLES 1 0.0002
534 HAEMORRHOIDS 3 0.0002
535 CEREBROVASCULAR ACCIDENT 26 0.0002
536 POLYP 1 0.0002
537 CHOLELITHIASIS 5 0.0002
538 IMMUNE SYSTEM DISORDER 2 0.0002
539 TOOTH INFECTION 2 0.0002
540 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
541 APPETITE DISORDER 1 0.0002
542 ADVERSE REACTION 2 0.0002
543 FUNGAL INFECTION 5 0.0001
544 EYE HAEMORRHAGE 2 0.0001
545 THERAPEUTIC RESPONSE DECREASED 9 0.0001
546 SUICIDE ATTEMPT 9 0.0001
547 SINUS CONGESTION 2 0.0001
548 PLEURAL EFFUSION 9 0.0001
549 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
550 ECCHYMOSIS 1 0.0001
551 SKIN LESION 4 0.0001
552 PERIPHERAL COLDNESS 2 0.0001
553 ORAL DISCOMFORT 2 0.0001
554 ACUTE KIDNEY INJURY 22 0.0001
555 EXTRASYSTOLES 1 0.0001
556 WOUND 4 0.0001
557 BLOOD TEST ABNORMAL 2 0.0001
558 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
559 HEADACHE 89 0.0001
560 DUODENAL ULCER 1 0.0001
561 MUSCLE SPASMS 26 0.0001
562 PAIN IN JAW 4 0.0001
563 DIVERTICULUM 1 0.0001
564 PARAESTHESIA 22 0.0001
565 PARAESTHESIA ORAL 2 0.0001
566 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
567 HYPOKINESIA 2 0.0001
568 FATIGUE 107 0.0001
569 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
570 RENAL FAILURE 18 0.0001
571 URINARY INCONTINENCE 4 0.0001
572 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
573 CONSTIPATION 29 0.0001
574 BREAST TENDERNESS 1 0.0001
575 HYPOAESTHESIA ORAL 2 0.0001
576 HAEMODYNAMIC INSTABILITY 1 0.0001
577 LIPASE INCREASED 1 0.0001
578 DISSOCIATION 1 0.0001
579 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
580 HAEMOLYSIS 1 0.0001
581 CONCUSSION 1 0.0001
582 APHTHOUS ULCER 1 0.0001
583 HYPOALBUMINAEMIA 1 0.0001
584 HAEMORRHAGIC STROKE 1 0.0001
585 GASTROINTESTINAL INFLAMMATION 1 0.0001
586 BRAIN FOG 2 0.0001
587 FURUNCLE 1 0.0001
588 LOW BIRTH WEIGHT BABY 1 0.0001
589 GINGIVAL PAIN 1 0.0001
590 CYSTITIS 4 0.0001
591 MOOD SWINGS 4 0.0001
592 SCIATICA 2 0.0001
593 ATRIAL FLUTTER 1 0.0001
594 THROMBOCYTOPENIA 14 0.0001
595 SOMNOLENCE 25 0.0001
596 FRUSTRATION TOLERANCE DECREASED 1 0.0001
597 LACTIC ACIDOSIS 4 0.0001
598 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
599 NEURALGIA 3 0.0001
600 ASTHENIA 46 0.0001
601 DIZZINESS 61 0.0001
602 PAIN IN EXTREMITY 36 0.0001
603 ABNORMAL FAECES 1 0.0001
604 HICCUPS 1 0.0001
605 EYE DISORDER 4 0.0001
606 HAIR DISORDER 1 0.0001
607 PHOTOSENSITIVITY REACTION 2 0.0001
608 MUSCLE INJURY 1 0.0001
609 COAGULOPATHY 2 0.0001
610 POLLAKIURIA 5 0.0001
611 INFUSION SITE ERYTHEMA 1 0.0001
612 BLOOD PRESSURE INCREASED 18 0.0001
613 FACIAL PARALYSIS 1 0.0001
614 HAEMATURIA 4 0.0001
615 DYSPNOEA 66 0.0001
616 GASTRIC DISORDER 4 0.0001
617 MUSCLE STRAIN 1 0.0001
618 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
619 HAEMORRHAGE 12 0.0001
620 LOCAL SWELLING 2 0.0001
621 NAIL DISORDER 1 0.0001
622 BLOOD CALCIUM INCREASED 1 0.0001
623 IMMUNOSUPPRESSION 1 0.0001
624 LUNG INFILTRATION 1 0.0001
625 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
626 HEAD DISCOMFORT 2 0.0001
627 EAR INFECTION 3 0.0001
628 FACIAL PAIN 1 0.0001
629 PULMONARY OEDEMA 5 0.0001
630 BLOOD BILIRUBIN INCREASED 3 0.0001
631 PNEUMONITIS 3 0.0001
632 LIP DRY 1 0.0001
633 DIARRHOEA 71 0.0001
634 BONE DISORDER 2 0.0001
635 HYPOTENSION 22 0.0001
636 END STAGE RENAL DISEASE 2 0.0001
637 INFLUENZA LIKE ILLNESS 9 0.0001
638 MEMORY IMPAIRMENT 15 0.0001
639 INTENTIONAL OVERDOSE 7 0.0001
640 TINNITUS 5 0.0001
641 BLOOD GLUCOSE ABNORMAL 2 0.0001
642 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
643 WEIGHT DECREASED 30 0.0001
644 ERYTHEMA MULTIFORME 1 0.0001
645 BACTERIAL INFECTION 2 0.0001
646 NEPHROPATHY 1 0.0001
647 INTESTINAL OBSTRUCTION 4 0.0001
648 LEUKAEMIA 1 0.0001
649 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
650 ARRHYTHMIA 5 0.0001
651 FOOT FRACTURE 2 0.0001
652 BLOOD PRESSURE DECREASED 7 0.0001
653 FALL 35 0.0001
654 MUSCULOSKELETAL DISORDER 2 0.0001
655 PULMONARY FIBROSIS 2 0.0001
656 AFFECT LABILITY 1 0.0001
657 HYPERCHOLESTEROLAEMIA 1 0.0001
658 ATELECTASIS 1 0.0001
659 BONE PAIN 6 0.0001
660 PHARYNGEAL SWELLING 1 0.0001
661 KNEE OPERATION 1 0.0001
662 DISEASE PROGRESSION 12 0.0001
663 HOSPICE CARE 1 0.0001
664 SINUS DISORDER 2 0.0001
665 ABNORMAL BEHAVIOUR 4 0.0001
666 BLOOD PRESSURE ABNORMAL 2 0.0001
667 ABORTION SPONTANEOUS 4 0.0001
668 BURNING SENSATION 7 0.0001
669 APHASIA 3 0.0001
670 LACRIMATION INCREASED 3 0.0001
671 PRODUCT PHYSICAL ISSUE 2 0.0001
672 CORONARY ARTERY DISEASE 3 0.0001
673 EYELID PTOSIS 1 0.0001
674 MOTOR DYSFUNCTION 1 0.0001
675 DEHYDRATION 13 0.0001
676 HYPERBILIRUBINAEMIA 1 0.0001
677 SWELLING 9 0.0001
678 SWOLLEN TONGUE 3 0.0001
679 DERMATITIS 2 0.0001
680 WITHDRAWAL SYNDROME 4 0.0001
681 INJECTION SITE DISCOMFORT 1 0.0001
682 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
683 MOUTH ULCERATION 2 0.0001
684 HEAD INJURY 3 0.0001
685 BACK PAIN 22 0.0001
686 NEUROPATHY PERIPHERAL 9 0.0001
687 HYPOTHYROIDISM 3 0.0001
688 BREAST PAIN 1 0.0001
689 JOINT INJURY 2 0.0001
690 COUGH 26 0.0001
691 ATRIAL FIBRILLATION 9 0.0001
692 OEDEMA 5 0.0001
693 SEPTIC SHOCK 4 0.0001
694 PRURITUS 35 0.0001
695 MELAENA 2 0.0001
696 INJECTION SITE NODULE 1 0.0001
697 DENTAL CARIES 1 0.0001
698 EXPIRED PRODUCT ADMINISTERED 3 0.0001
699 TRANSAMINASES INCREASED 2 0.0001
700 NERVE INJURY 1 0.0001
701 INFECTION 13 0.0001
702 ABDOMINAL DISCOMFORT 15 0.0001
703 ORAL PAIN 2 0.0001
704 EYE INFECTION 1 0.0001
705 MUSCULAR WEAKNESS 10 0.0001
706 IMPAIRED DRIVING ABILITY 1 0.0001
707 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
708 INTERNAL HAEMORRHAGE 1 0.0001
709 NEPHROLITHIASIS 4 0.0001
710 GASTRIC HAEMORRHAGE 1 0.0001
711 DRY MOUTH 7 0.0001
712 MADAROSIS 1 0.0001
713 ELECTROLYTE IMBALANCE 1 0.0001
714 ABDOMINAL PAIN 20 0.0001
715 RASH MACULAR 3 0.0001
716 BLOOD CHOLESTEROL INCREASED 4 0.0001
717 COGNITIVE DISORDER 4 0.0001
718 CARDIAC DISORDER 8 0.0001
719 HYPERTENSION 18 0.0001
720 CARDIAC ARREST 7 0.0001
721 HOSPITALISATION 13 0.0001
722 ATAXIA 1 0.0001
723 BACTERAEMIA 1 0.0001
724 MACULAR DEGENERATION 1 0.0001
725 ACCIDENT 1 0.0001
726 INCORRECT DOSE ADMINISTERED 19 0.0001
727 MENTAL IMPAIRMENT 2 0.0001
728 STOMATITIS 5 0.0001
729 RESPIRATORY FAILURE 6 0.0001
730 DYSURIA 3 0.0001
731 CARDIOMEGALY 1 0.0001
732 BRONCHITIS 6 0.0001
733 ILEUS 1 0.0001
734 HAIR COLOUR CHANGES 1 0.0001
735 DRY EYE 4 0.0001
736 MUSCLE ATROPHY 1 0.0001
737 FLUID RETENTION 4 0.0001
738 ERECTILE DYSFUNCTION 2 0.0001
739 ABDOMINAL PAIN UPPER 16 0.0001
740 HYPERHIDROSIS 10 0.0001
741 INFUSION SITE PAIN 1 0.0001
742 HIATUS HERNIA 1 0.0001
743 PNEUMONIA 25 0.0001
744 DIPLOPIA 2 0.0001
745 AMNESIA 5 0.0001
746 NERVOUSNESS 4 0.0001
747 MUCOSAL INFLAMMATION 2 0.0001
748 JOINT STIFFNESS 2 0.0001
749 ANKYLOSING SPONDYLITIS 1 0.0001
750 HAIR TEXTURE ABNORMAL 1 0.0001
751 MALIGNANT MELANOMA 1 0.0001
752 JAUNDICE 2 0.0001
753 RASH PRURITIC 4 0.0001
754 PALLOR 2 0.0001
755 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
756 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
757 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
758 TREATMENT FAILURE 6 0.0001
759 DIVERTICULITIS 2 0.0001
760 PROCEDURAL PAIN 2 0.0001
761 HYPOMAGNESAEMIA 1 0.0001
762 HUNGER 1 0.0001
763 INFLUENZA 8 0.0001
764 ROAD TRAFFIC ACCIDENT 3 0.0001
765 NECK PAIN 4 0.0001
766 CARPAL TUNNEL SYNDROME 1 0.0001
767 DYSPEPSIA 7 0.0001
768 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
769 DEVICE OCCLUSION 1 0.0001
770 FEELING ABNORMAL 17 0.0001
771 HEART RATE INCREASED 7 0.0001
772 URINARY TRACT INFECTION 12 0.0001
773 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
774 INTENTIONAL DOSE OMISSION 2 0.0001
775 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
776 THERAPY INTERRUPTED 5 0.0001
777 RECTAL HAEMORRHAGE 3 0.0001
778 ANGINA PECTORIS 2 0.0001
779 HYPOACUSIS 3 0.0001
780 IMPAIRED QUALITY OF LIFE 1 0.0001
781 LETHARGY 4 0.0001
782 EYE IRRITATION 4 0.0001
783 PYREXIA 24 0.0001
784 PANCREATIC CARCINOMA 2 0.0001
785 VAGINAL HAEMORRHAGE 3 0.0001
786 ANOSMIA 1 0.0001
787 APATHY 1 0.0001
788 GAIT DISTURBANCE 13 0.0001
789 LIVER DISORDER 3 0.0001
790 RENAL INJURY 2 0.0001
791 DEATH 58 0.0001
792 COLON CANCER 1 0.0001
793 HYPOAESTHESIA 10 0.0001
794 THERAPY NON-RESPONDER 3 0.0001
795 ALOPECIA 13 0.0001
796 NEUTROPENIA 9 0.0001
797 DEVICE FAILURE 1 0.0001
798 SKIN IRRITATION 3 0.0001
799 TOXICITY TO VARIOUS AGENTS 11 0.0001
800 DEVICE RELATED INFECTION 1 0.0001
801 PERIPHERAL SWELLING 10 0.0001
802 CHEST PAIN 12 0.0001
803 LYMPHOMA 1 0.0001
804 PRODUCT DOSE OMISSION ISSUE 19 0.0001
805 MUSCULOSKELETAL CHEST PAIN 1 0.0001
806 ANKLE FRACTURE 1 0.0001
807 DECREASED APPETITE 15 0.0001
808 NAUSEA 51 0.0001
809 DELUSION 1 0.0001
810 EXPOSURE DURING PREGNANCY 4 0.0001
811 RASH 28 0.0001
812 MALAISE 28 0.0001
813 INSOMNIA 17 0.0001
814 ARTHRITIS 5 0.0001
815 DYSPHAGIA 6 0.0001
816 MYOCARDIAL INFARCTION 11 0.0001
817 HALLUCINATION, AUDITORY 1 0.0001
818 SEPSIS 7 0.0001
819 COVID-19 11 0.0001
820 MOVEMENT DISORDER 2 0.0001
821 MUSCLE TIGHTNESS 1 0.0001
822 BACK DISORDER 1 0.0001
823 SWELLING FACE 4 0.0001
824 DRUG LEVEL INCREASED 1 0.0001
825 FEBRILE NEUTROPENIA 4 0.0001
826 NEOPLASM MALIGNANT 4 0.0001
827 HYPERSENSITIVITY 11 0.0001
828 VISION BLURRED 8 0.0001
829 MUSCULOSKELETAL PAIN 3 0.0001
830 HEART RATE DECREASED 2 0.0001
831 HYPOXIA 2 0.0001
832 DEPRESSED MOOD 3 0.0001
833 DRUG INTERACTION 9 0.0001
834 SLEEP DISORDER 4 0.0001
835 LYMPHOCYTE COUNT DECREASED 1 0.0001
836 LYMPHADENOPATHY 2 0.0001
837 DRUG ERUPTION 1 0.0001
838 ISCHAEMIC STROKE 1 0.0001
839 MOBILITY DECREASED 4 0.0001
840 DISTURBANCE IN ATTENTION 3 0.0001
841 HEPATIC FUNCTION ABNORMAL 2 0.0001
842 MIDDLE INSOMNIA 1 0.0001
843 HALLUCINATION 4 0.0001
844 HOT FLUSH 4 0.0001
845 BLOOD SODIUM DECREASED 1 0.0001
846 ACNE 4 0.0001
847 DEPRESSION 12 0.0001
848 GASTRIC ULCER 1 0.0001
849 PULMONARY EMBOLISM 5 0.0001
850 FEELING JITTERY 1 0.0001
851 DRUG PRESCRIBING ERROR 1 0.0001
852 GLAUCOMA 1 0.0001
853 HERNIA 1 0.0001
854 ERUCTATION 1 0.0001
855 DRUG INEFFECTIVE 68 0.0001
856 EAR PAIN 1 0.0001
857 CHOKING 1 0.0001
858 KIDNEY INFECTION 1 0.0001
859 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
860 DISORIENTATION 2 0.0001
861 COMPLICATION OF DEVICE INSERTION 1 0.0001
862 JOINT SWELLING 6 0.0000
863 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
864 EXTRA DOSE ADMINISTERED 2 0.0000
865 VOMITING 23 0.0000
866 PERITONITIS 1 0.0000
867 OSTEOARTHRITIS 2 0.0000
868 EATING DISORDER 1 0.0000
869 DEEP VEIN THROMBOSIS 3 0.0000
870 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
871 ANXIETY 13 0.0000
872 APPLICATION SITE PAIN 1 0.0000
873 HEPATOTOXICITY 1 0.0000
874 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
875 THROAT IRRITATION 2 0.0000
876 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
877 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
878 CHROMATURIA 1 0.0000
879 ASTHMA 5 0.0000
880 PAIN 27 0.0000
881 MUSCLE TWITCHING 1 0.0000
882 HYPOKALAEMIA 2 0.0000
883 CONFUSIONAL STATE 7 0.0000
884 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
885 OROPHARYNGEAL PAIN 4 0.0000
886 CONDITION AGGRAVATED 13 0.0000
887 CHILLS 5 0.0000
888 BLOOD GLUCOSE INCREASED 8 0.0000
889 PRODUCTIVE COUGH 2 0.0000
890 SKIN BURNING SENSATION 3 0.0000
891 RASH ERYTHEMATOUS 2 0.0000
892 URTICARIA 7 0.0000
893 BLOOD PRESSURE FLUCTUATION 1 0.0000
894 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
895 INTERSTITIAL LUNG DISEASE 2 0.0000
896 MYALGIA 7 0.0000
897 FIBROMYALGIA 1 0.0000
898 ARTHRALGIA 17 0.0000
899 ENCEPHALOPATHY 1 0.0000
900 SYNCOPE 4 0.0000
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
902 ABDOMINAL PAIN LOWER 1 0.0000
903 HAEMATEMESIS 1 0.0000
904 DIABETES MELLITUS 3 0.0000
905 HYPOPHAGIA 1 0.0000
906 CHEST DISCOMFORT 4 0.0000
907 SINUSITIS 4 0.0000
908 THERAPY CESSATION 2 0.0000
909 INFLAMMATION 2 0.0000
910 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
911 ECZEMA 2 0.0000
912 APPLICATION SITE ERYTHEMA 1 0.0000
913 DRUG EFFECT DECREASED 2 0.0000
914 ABNORMAL DREAMS 1 0.0000
915 TREMOR 6 0.0000
916 MENTAL STATUS CHANGES 1 0.0000
917 DEMENTIA 1 0.0000
918 BLISTER 2 0.0000
919 SKIN EXFOLIATION 3 0.0000
920 EYE PAIN 2 0.0000
921 HYPERSOMNIA 1 0.0000
922 PRODUCT SUBSTITUTION ISSUE 2 0.0000
923 BALANCE DISORDER 3 0.0000
924 DYSSTASIA 1 0.0000
925 DYSPHONIA 2 0.0000
926 ERYTHEMA 7 0.0000
927 ASCITES 1 0.0000
928 BLADDER CANCER 2 0.0000
929 GASTROINTESTINAL DISORDER 3 0.0000
930 IRRITABILITY 2 0.0000
931 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
932 DISCOMFORT 2 0.0000
933 EPILEPSY 1 0.0000
934 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
935 NASOPHARYNGITIS 6 0.0000
936 EMOTIONAL DISORDER 1 0.0000
937 LIMB DISCOMFORT 1 0.0000
938 FEMUR FRACTURE 1 0.0000
939 VISUAL IMPAIRMENT 4 0.0000
940 BREAST CANCER 3 0.0000
941 NERVOUS SYSTEM DISORDER 1 0.0000
942 DRUG-INDUCED LIVER INJURY 1 0.0000
943 MIGRAINE 3 0.0000
944 HIP FRACTURE 1 0.0000
945 RHINORRHOEA 2 0.0000
946 LIP SWELLING 1 0.0000
947 DRY SKIN 4 0.0000
948 GAIT INABILITY 1 0.0000
949 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
950 ILLNESS 3 0.0000
951 NIGHTMARE 1 0.0000
952 NEOPLASM PROGRESSION 1 0.0000
953 HYPERKALAEMIA 1 0.0000
954 INJURY 2 0.0000
955 MYELOSUPPRESSION 1 0.0000
956 DYSGEUSIA 2 0.0000
957 DYSARTHRIA 1 0.0000
958 UNEVALUABLE EVENT 2 0.0000
959 SEIZURE 3 0.0000
960 BLINDNESS 1 0.0000
961 NEUTROPHIL COUNT DECREASED 1 0.0000
962 OSTEOPOROSIS 1 0.0000
963 CARDIO-RESPIRATORY ARREST 1 0.0000
964 DEVICE LEAKAGE 1 0.0000
965 PRODUCT STORAGE ERROR 2 0.0000
966 ADVERSE EVENT 2 0.0000
967 PRODUCT USE ISSUE 4 0.0000
968 DISEASE RECURRENCE 1 0.0000
969 COLORECTAL CANCER 1 0.0000
970 AGGRESSION 1 0.0000
971 FLUSHING 2 0.0000
972 PANCREATITIS 1 0.0000
973 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
974 HAEMATOCHEZIA 1 0.0000
975 MEDICATION ERROR 1 0.0000
976 OXYGEN SATURATION DECREASED 1 0.0000
977 NASAL CONGESTION 1 0.0000
978 CATARACT 1 0.0000
979 EMOTIONAL DISTRESS 2 0.0000
980 ILL-DEFINED DISORDER 1 0.0000
981 FEELING HOT 1 0.0000
982 LOSS OF CONSCIOUSNESS 2 0.0000
983 PSORIASIS 2 0.0000
984 INFUSION RELATED REACTION 1 0.0000
985 INJECTION SITE PRURITUS 1 0.0000
986 INJECTION SITE BRUISING 1 0.0000
987 INJECTION SITE HAEMORRHAGE 1 0.0000
988 INTENTIONAL PRODUCT MISUSE 1 0.0000
989 MUSCULOSKELETAL STIFFNESS 1 0.0000
990 DEVICE ISSUE 1 0.0000
991 ADVERSE DRUG REACTION 1 0.0000
992 OVERDOSE 2 0.0000
993 INJECTION SITE ERYTHEMA 1 0.0000
994 INJECTION SITE PAIN 2 0.0000